ERBB2 and breast carcinoma: In order to evaluate the cell senescence in LAP treatment, we first assessed the effects of LAP on HER2+ breast cancer cell line, and SKBR3 cell line (herein referred to SK) was exposed to LAP at different concentrations for 24 h.